ClinicalTrials.gg
RecruitingNCT07883018SLEEVE15Updated Oct 20, 2026

15-years Outcomes of Sleeve Gastrectomy on Weight Loss

An observational study in Bariatric Surgery, Sleeve Gastrectomy and Weight Loss, sponsored by Centre Hospitalier Universitaire, Amiens. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Centre Hospitalier Universitaire, Amiens · Observational

Updated Oct 20, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

Evaluate the beneficial and harmful effects of sleeve gastrectomy at 15 years in a pioneering center for this surgical technique in France

02

Conditions studied

  • Bariatric Surgery
  • Sleeve Gastrectomy
  • Weight Loss

Browse trials for

Keywords

  • bariatric surgery
  • sleeve gastrectomy
  • weight loss
03

In context

Weight Loss

1,818 studies on the registry are indexed under Weight Loss; 286 are open to participants now.

This study's planned enrollment of 300 is above the median of 95 across 226 observational studies indexed under Weight Loss.

Browse Weight Loss studies →

Lead sponsor

Centre Hospitalier Universitaire, Amiens is the lead sponsor of 582 studies on the registry; 181 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

adult patients who underwent sleeve gastrectomy between 2004 and 2010

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult patients who underwent sleeve gastrectomy between 2004 and 2010

Exclusion criteria

Exclusion Criteria:

  • patients under 18 year old, pregnancy
  • temporary or permanent under guardians
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
300 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. weight loss

    Time frame: 15 minutes

Secondary outcomes

  1. number of obesity-related comorbidities 15 years after surgery

    number of obesity-related comorbidities 15 years after surgery

    Time frame: 15 minutes

  2. surgical failure rate

    Time frame: 15 minutes

  3. reoperation rate

    Time frame: 15 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07883018
Responsible party
Sponsor
First posted
Oct 20, 2026
Start date
Oct 6, 2026
Primary completion
Oct 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Oct 20, 2026

Study contacts

Fabien WEREY, MD
Contact
werey.fabien@chu-amiens.fr
33+3 22 08 80 00

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion